REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search-icon
News

The Advantages of CAR T-Cell Therapy at Sheba Medical Center in Israel

CAR T-Cell Therapy
Not only is Sheba Medical Center one of only a handful of medical centers in the world to provide revolutionary CAR-T therapy, but there are many additional unique benefits to receiving the treatment at Sheba.

CAR cells must undergo extensive processing before they are ready to be administered to the patient. At Sheba, CARs are engineered in-house in a specialized laboratory. As a result, the entire process from lymphocyte collection to patient delivery only takes about 10 days. In contrast, many other hospitals use commercial CARs, which must be engineered abroad and shipped, taking months to become available. This delay allows the patient’s disease to progress further, which can also reduce the effectiveness of the body’s response to the CARs. Also, the shipping process compromises cell quality, as some cells die during the necessary freezing and thawing.

While commercial CARs are only approved for use in a few illnesses, Sheba’s CARs can be administered for a wide range of illnesses, including:

Sheba’s extensive experience with CAR T-cell therapy speaks louder than words. Under the expertise of Prof. Arnon Nagler, Director of the Hemato-Oncology Division and a world renowned specialist in the field, we have provided over 220 patients with CAR-T therapy, including about 60 children.

CAR T-Cell Therapy
Related
Sheba DUNS 100

For The Second Consecutive Year: Sheba Tops the Healthcare Sector on Dun & Bradstreet’s List of Leading Organizations

Dun & Bradstreet, the world’s foremost commercial data company, ranked 71 doctors from Sheba Medical Center in its list of the top Israeli clinical experts.…
Read More

Ayelet’s Miracle: The First Woman to Conceive Four Children Following Ovarian Tissue Cryopreservation

At 21, Ayelet Rozenberg was diagnosed with Hodgkin’s lymphoma. Facing aggressive therapies necessary to save her life, Ayelet feared she would never be able to…
Read More
bowel disease
News Sep 07.

Sheba Partners with Biomica to Advance Inflammatory Bowel Disease Care

As part of the new collaboration, Sheba and Biomica will engage in joint microbiome clinical research to develop better treatments for inflammatory bowel disease (IBD)…
Read More